A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate

Am J Gastroenterol. 1996 Mar;91(3):423-33.

Author

Affiliation

¹ Inflammatory Bowel Disease Clinic, Division of Gastroenterology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota USA.

PMID: 8633486

No abstract available

Publication types

Review

MeSH terms

Algorithms
Azathioprine / adverse effects
Azathioprine / pharmacology
Azathioprine / therapeutic use*
Controlled Clinical Trials as Topic
Cyclosporine / adverse effects
Cyclosporine / pharmacology
Cyclosporine / therapeutic use*
Humans
Immunosuppressive Agents / adverse effects
Immunosuppressive Agents / pharmacology
Immunosuppressive Agents / therapeutic use*
Inflammatory Bowel Diseases / drug therapy*
Inflammatory Bowel Diseases / immunology
Mercaptopurine / adverse effects
Mercaptopurine / pharmacology
Mercaptopurine / therapeutic use*
Methotrexate / adverse effects
Methotrexate / pharmacology
Methotrexate / therapeutic use*

Substances

Immunosuppressive Agents
Cyclosporine
Mercaptopurine
Azathioprine
Methotrexate